Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
Tubular damage is a recognized feature of both overt diabetic nephropathy and glomerulonephritis. However, the pattern and mechanism of tubular damage in the two clinical settings remain unclear. Two groups of patients with macroalbuminuria (albuminuria > 300 mg/day) were studied. Group 1 comprised 41 patients with biopsy proven primary glomerulonephritis and group 2 comprised 28 patients with clinical diabetic nephropathy due to insulin dependent diabetes mellitus. Serum creatinine, creatinine clearance, glomerular proteinuria (albuminuria and transferrinuria), markers of tubular damage such as urinary excretion of lysosomal enzyme (N-acetyl glucosaminidase), brush border enzymes (leucine aminopeptidase and gamma-glutamyl transferase) and retinol binding protein (tubular protein) were measured. Both groups were comparable in serum creatinine, creatinine clearance, glomerular proteinuria and excretion of N-acetyl-glucosaminidase. However, a significantly higher degree of tubular brush border enzymuria and a lower level of tubular proteinuria were seen in group 1 than in group 2. In group 1, albuminuria correlated to tubular enzymuria and tubular proteinuria. However, there was no correlation in diabetic patients between parameters of glomerular and tubular damage or dysfunction. The data presented suggested that the pattern of tubulopathy is different in patients with comparable degree of macroalbuminuria due to diabetic nephropathy and glomerulonephritis. Moreover, in diabetic nephropathy contrary to glomerulonephritis, markers of tubular damage are unrelated to glomerular proteinuria. This may suggest different mechanisms of tubular damage in the two clinical settings. We recommended that in all patients with proteinuria, particularly those with diabetic nephropathy, markers of renal tubular damage may be useful in monitoring the course of their disease.
Yaqoob
M
M
Royal Liverpool Hospital, England, United Kingdom.
McClelland
P
P
Patrick
A W
AW
Stevenson
A
A
Mason
H
H
Bell
G M
GM
D000118:Acetylglucosaminidase / Q000652:urine; D000328:Adult; D000419:Albuminuria / Q000201:enzymology / Q000209:etiology* / Q000652:urine; D015415:Biomarkers / Q000652:urine; D003404:Creatinine / Q000378:metabolism; D003928:Diabetic Nephropathies / Q000150:complications* / Q000201:enzymology / Q000652:urine; D005260:Female; D005921:Glomerulonephritis / Q000150:complications* / Q000201:enzymology / Q000652:urine; D006801:Humans; D007684:Kidney Tubules / Q000293:injuries; D007931:Leucyl Aminopeptidase / Q000652:urine; D008297:Male; D008875:Middle Aged; D012177:Retinol-Binding Proteins / Q000652:urine; D014168:Transferrin / Q000652:urine; D005723:gamma-Glutamyltransferase / Q000652:urine
D015415:Biomarkers; D012177:Retinol-Binding Proteins; D014168:Transferrin; D003404:Creatinine; D005723:gamma-Glutamyltransferase; D000118:Acetylglucosaminidase; D007931:Leucyl Aminopeptidase